» Articles » PMID: 22731761

Clinical Evaluation of the Computerized Chronic Urticaria-specific Quality of Life Questionnaire in Korean Patients with Chronic Urticaria

Overview
Specialty Dermatology
Date 2012 Jun 27
PMID 22731761
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chronic urticaria (CU) is a common skin disorder that affects the well-being and quality of life (QOL) of patients. Recently, we developed and validated a questionnaire for measuring QOL in Korean patients with CU, called the Chronic Urticaria-Specific Quality of Life (CU-QOL) questionnaire.

Aim: To evaluate the clinical significance of a computerized version of the CU-QOL, in adult patients with CU.

Methods: This was a cross-sectional observational study that enrolled 249 Korean patients with CU from five university hospitals and measured computerized CU-QOL scores and Urticaria Activity Score (UAS) simultaneously. The internal consistency of the computerized CU-QOL was analysed using Cronbach α. To identify clinical correlations between the CU-QOL and patient characteristics, the atopic status and serum autoantibodies, including antinuclear, antithyroglobulin and antimicrosome antibodies, were measured. Multiple linear regression models were used to identify CU-QOL predictors.

Results: Cronbach α was 0.94 for the overall computerized CU-QOL score. The CU-QOL scores correlated significantly with the UAS (r= -0.49, P<0.001). Of the factors aggravating CU, delayed pressure, sunlight exposure and emotional stress significantly influenced the overall CU-QOL scores in the univariate analysis. Multivariate regression models indicated that UAS and emotional stress were significant predictors of the four domains and of the total CU-QOL scores.

Conclusions: The computerized CU-QOL is a convenient and valid tool for measuring QOL in patients with CU. This study suggests that UAS, dermatographism and emotional stress are strong CU-QOL predictors in Korean patients with CU.

Citing Articles

Efficacy of Second-Line Treatments in Chronic Urticaria Refractory to Standard Dose Antihistamines.

Kim M, Choi J, Shin Y, Park H, Ye Y Allergy Asthma Immunol Res. 2023; 15(4):496-511.

PMID: 37153977 PMC: 10359646. DOI: 10.4168/aair.2023.15.4.496.


The burden of symptomatic patients with chronic spontaneous urticaria: a real-world study in Korea.

Ye Y, Koh Y, Choi J, Kim M, Park J, Kim T Korean J Intern Med. 2022; 37(5):1050-1060.

PMID: 36068718 PMC: 9449199. DOI: 10.3904/kjim.2022.078.


Angioedema Coexisting Chronic Spontaneous Urticaria Negatively Influences Patients' Sense of Coherence, What Results in Susceptibility to Anxiety Symptoms Occurrence.

Badura-Brzoza K, Brzoza Z J Clin Med. 2021; 10(13).

PMID: 34203132 PMC: 8268328. DOI: 10.3390/jcm10132852.


Medication Requirements for Disease Control Predict the Prognosis of Chronic Urticaria.

Choi J Allergy Asthma Immunol Res. 2021; 13(3):357-359.

PMID: 33733631 PMC: 7984949. DOI: 10.4168/aair.2021.13.3.357.


The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 2. Management of H1-Antihistamine-Refractory Chronic Urticaria.

Choi J, Lee D, Song W, Choi M, Kwon J, Kim G Allergy Asthma Immunol Res. 2020; 12(5):750-770.

PMID: 32638557 PMC: 7346997. DOI: 10.4168/aair.2020.12.5.750.